Top-line results from SUMMIT trial in NonAdvSM patients expected July 2025• APEX trial enrollment in AdvSM patients complete; top-line results ...

A live webcast of the presentation will be available under the “ Events ” tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be posted on the ...

Mini-Stem System® received its CE Mark approval in 2024 Dr. Neophytos Demetriades, Dr. Marco Spoliti, and Dr. Francesco Calvani ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...

GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...

GSK plc (LSE/NYSE: GSK) today announced that it has completed the acquisition of IDRx, Inc. (IDRx), a Boston-based, ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has appointed Dr.

GSK on Monday also said it has start the GBP2 billion buyback programme that it announced earlier this month, starting with an initial GBP700 million tranche.

Chen, D. and Li, L. (2025) Huge Pelvic GIST Got Good Control after Resistance to Tyrosine Kinase Inhibitors by SIB-IMRT: A ...

The European Society for Medical Oncology (ESMO) guidelines recommend life-long systemic tyrosine kinase inhibitor (TKI) ...

Learn about Pseudoangiomatous Stromal Hyperplasia (PASH) of the breast, its diagnosis, hormonal influences, and holistic ...